An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized TrialMasahiro Natsuaki, Takeshi Kimura, Kenji Andò et al.|Circulation|2023Cited by 145
Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary InterventionHirotoshi Watanabe, Takeshi Kimura, Takeshi Morimoto et al.|Journal of the American College of Cardiology|2023Cited by 62
Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trialHirotoshi Watanabe, Takeshi Kimura, Masahiro Natsuaki et al.|European Heart Journal|2024Cited by 37